ANDA Approvals - New Drug Applications and 505(b)(2) Applications: Third Quarter
15 Nov 2024 22:16 GMT
… ;2024
Cupric Sulfate
Cupric Sulfate
Abraxis
Apotex
218745
08/20 … /2024
Cubicin
Daptomycin
Cubist
Biocon Pharma
217215
08/29 …
Entresto
Sacubitril / Valsartan
Novartis
Biocon Pharma
213680
09/03 …
Who are the top 32 self made billionaires?
17 Apr 2023 12:12 GMT
… Chairperson and Founder for Biocon Limited and Biocon Biologics Limited, Kiran … a current 40% stake in Biocon.
She started her biotech … approached by the owner of Biocon Biochemicals, an Irish speciality … Shiong sold his drug company Abraxis, and in 2008 sold …
2022 Worldwide Para IV Insights Database - Featuring 3M, Abbott and Abbvie Among Others - ResearchAndMarkets.com
18 Mar 2022 12:38 GMT
…
Abbvie
Abhai
Abon Pharmaceuticals LLC
Abraxis
Abrika
Acadia Pharma
Accord (Intas … Pharma
Beljing
Beloteca, Inc.
Benvenue
Biocon
Biodelivery Sciences
BIOFRONTERA INC
Biogen …
Global Cancer mTOR Inhibitors Market & Clinical Pipeline Outlook 2018-2022 - 27 mTOR Inhibitors in Pipeline & In-Depth Dosage/Price Analysis of 10 Cancer mTOR Inhibitors Drugs Commercially Available
26 Feb 2018 11:08 GMT
… .4 Evertor - Everolimus by Biocon
11. Market Performance Analysis of …
11.1.3 Evertor by Biocon
12. Comparative Cost Analysis of …
16. Competitive Landscape
16.1 Abraxis BioScience
16.2 Adimab
16 …
Cancer mTOR Inhibitors Market & Clinical Pipeline Market, 2022
26 Feb 2018 17:35 GMT
… .4 Evertor - Everolimus by Biocon
11. Market Performance Analysis of …
11.1.3 Evertor by Biocon
12. Comparative Cost Analysis of …
16. Competitive Landscape
16.1 Abraxis BioScience
16.2 Adimab
16 …
Global Cancer mTOR Inhibitors Market & Clinical Pipeline Outlook 2018-2022 - 27 mTOR Inhibitors in Pipeline & In-Depth Dosage/Price Analysis of 10 Cancer mTOR Inhibitors Drugs Commercially Available
26 Feb 2018 11:04 GMT
… .4 Evertor - Everolimus by Biocon
11. Market Performance Analysis of …
11.1.3 Evertor by Biocon
12. Comparative Cost Analysis of …
16. Competitive Landscape
16.1 Abraxis BioScience
16.2 Adimab
16 …